Cargando…
The Past, Present, and Future of Exudative Age-Related Macular Degeneration Treatment
Treatment of exudative age-related macular degeneration has been revolutionized within the last 6 years with the introduction of vascular endothelial growth factor neutralizing agents. Previously popular “destructive treatments,” such as laser photocoagulation and photodynamic treatment have either...
Autores principales: | Barak, Yoreh, Heroman, Wesley J., Tezel, Tongalp H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277024/ https://www.ncbi.nlm.nih.gov/pubmed/22346114 http://dx.doi.org/10.4103/0974-9233.92115 |
Ejemplares similares
-
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
por: García-Layana, Alfredo, et al.
Publicado: (2015) -
Use of 25% sulfur hexafluoride gas mixture may minimize short-term postoperative hypotony in sutureless 25-gauge pars plana vitrectomy surgery
por: Barak, Yoreh, et al.
Publicado: (2013) -
Stem cell therapies for age-related macular degeneration: the past, present, and future
por: Dang, Yalong, et al.
Publicado: (2015) -
NEI-Supported Age-Related Macular Degeneration Research: Past, Present, and Future
por: Wright, Charles, et al.
Publicado: (2020) -
Therapeutic Modalities of Exudative Age-related Macular Degeneration
por: Mavija, Milka, et al.
Publicado: (2014)